It is a machinery and equipment private limited company based in Mumbai, Maharashtra, India, established in 1998.
1998 | Mumbai, Maharashtra, India | AmalgamatedShri Hari Drugs And Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 14 December 1998 in Mumbai, Maharashtra, India. Engaging in industrial machinery retail & distribution within the machinery and equipment sector, it holds CIN: U24239MH1998PTC117449. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.20 M.
It upholds a compliant status. Its leadership includes Arun Kumar Bhalotia (Director), Ayush Arun Bhalotia (Director). Past directors included Sunita Arun Bhalotia, Anant Arun Bhalotia, Sunita Bhalotia. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 204 /205 Konark Shram2Nd Floor Behind Everstbldg 156 Tardev Road, Mumbai, Maharashtra, 400034.
U24239MH1998PTC117449
117449
14 December 1998
₹1.50 M
₹1.20 M
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Shri Hari Drugs And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Kumar Bhalotia | Director | 14 Dec 1998 | Current |
| Ayush Arun Bhalotia | Director | 01 Dec 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2009 | Past |
| Pramod Abcsdd | Director | 10 Mar 2016 | Past |
| Pramod Abcsdd | Director | 17 Jun 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shri Hari Drugs And Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 21.32% decrease. The company also saw a substantial improvement in profitability, with a 99.39% increase in profit. The company's net worth dipped by a decrease of 0.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Shri Hari Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shri Hari Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shri Hari Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Hari Drugs And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shri Hari Drugs And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Shri Hari Drugs And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was recorded as a recent event.
The activity Ayush Arun Bhalotia was appointed as a Director was appointed as a Director on 01 Dec 2006 & has been associated with this company since 19 years 1 month . was completed.
Progress on Arun Kumar Bhalotia was appointed as a Director was appointed as a Director on 14 Dec 1998 & has been associated with this company since 27 years 1 month . was documented.
Progress on Shri Hari Drugs And Pharmaceuticals Private Limited was registered on 14 Dec 1998 with Roc Mumbai & aged 27 years 1 month as per MCA records. was documented.
The CIN of Shri Hari Drugs And Pharmaceuticals Private Limited is U24239MH1998PTC117449.
Shri Hari Drugs And Pharmaceuticals Private Limited is headquartered at 204 /205 Konark Shram2Nd Floor Behind Everstbldg 156 Tardev Road, Mumbai, Maharashtra, 400034.
Shri Hari Drugs And Pharmaceuticals Private Limited was incorporated on 14 December 1998.
The current directors of Shri Hari Drugs And Pharmaceuticals Private Limited are
The primary industry of Shri Hari Drugs And Pharmaceuticals Private Limited is Machinery And Equipment.
Shri Hari Drugs And Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shri Hari Drugs And Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.20 M.
The compliance status of Shri Hari Drugs And Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX